MedWatch

Lundbeck on new climate plan: aims for carbon neutrality long before 2050

Subcontractors and distribution are the sore spots for Lundbeck's ability to met new climate goals of carbon neutrality, but CEO Deborah Dunsire is confident the firm can meet its goal before 2050.

Photo: BeGreen

Lundbeck's goal to become carbon neutral by 2050 heavily leans on the global Paris Agreement, but the pharmaceutical companies plans to reach this target before then, says Lundbeck CEO Deborah Dunsire in the wake of the company presenting its new climate plan.

"We will probably be moving our own internal operations toward carbon neutrality within the 2034 time frame, but the difficult part will be helping the supply chain, where the majority of our carbon footprint lies, to work with us to become carbon neutral," says Dunsire, who, however, is sympathetic towards the notion that the 2050 net-zero emissions goal lacks ambition.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs